Dosimetric effects of an air cavity for the SAVI™ partial breast irradiation applicator

Medical Physics

Volumn 37, Issue 8, 2010, Pages 3919-3926

  Richardson, Susan L ^a   Pino, Ramiro ^b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c Texas Cancer Clinic   (United States)

Author keywords

brachytherapy; heterogeneity; Monte Carlo; partial breast irradiation; SAVI

Indexed keywords

AIR; DOSIMETRY; IRRADIATION;

BRACHYTHERAPY; DOSE CALCULATION; HETEROGENEITY; INDEPENDENT MEASUREMENT; PARTIAL BREAST IRRADIATION; SAVI; TREATMENT PLANNING; TREATMENT PLANNING SYSTEMS;

MONTE CARLO METHODS;

ARTICLE; ARTIFACT; BRACHYTHERAPY; BREAST TUMOR; COMPUTER ASSISTED RADIOTHERAPY; EQUIPMENT; EQUIPMENT DESIGN; EVALUATION; FEMALE; HUMAN; INSTRUMENTATION; METHODOLOGY; RADIATION DOSE; RADIOMETRY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ARTIFACTS; BRACHYTHERAPY; BREAST NEOPLASMS; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FEMALE; HUMANS; RADIATION DOSAGE; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 78149482239     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3457328     Document Type: Article

References (20)

1. NSABP B-39/RTOG 0413 protocol, "A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, 1, or 2 breast cancer," http:// www.rtog.org/members/protocols/0413/0413.pdf.
2. R. R. Kuske and J. S. Bolton, A Phase I/II Trial to Evaluate Brachytherapy as the Sole Method of Radiation Therapy for Stage I and II Breast Carcinoma (RTOG Publication No. 1055) (Radiation Therapy Oncology Group, Philadelphia, 1995).
3. F. Vicini et al., "Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial breast irradiation in patient with early state breast cancer treated with breast conserving therapy," Int. J. Radiat. Oncol., Biol., Phys. 57, 1247-1253 (2003).
4. M. Keisch et al., "Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy," Int. J. Radiat. Oncol., Biol., Phys. 55(2), 289-293 (2003).
5. N. Shah et al., "MammoSite and interstitial brachytherapy for accelerated partial breast irradiation," Cancer 101(4), 727-734 (2004).
6. G. M. Richards et al., "Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer," Ann. Surg. Oncol. 11, 739-746 (2004).
7. V. Zannis et al., "Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial," Am. J. Surg. 190(4), 530-538 (2005).
8. F. A. Vicini et al., "Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI)," Cancer 112(4), 758-766 (2008).
9. A. Dickler, R. Patel, and D. Wazer, "Breast brachytherapy devices," Expert Rev. Med. Devices 6(3), 325-333 (2009).
10. S. Brown et al., "Initial radiation experience evaluating early tolerance and toxicities in patients undergoing accelerated partial breast irradiation using the Contura® Multi-Lumen Balloon breast brachytherapy catheter," Brachytherapy 8, 227-233 (2009).
11. A. Dorin et al., "Accelerated partial breast irradiation with the SenoRx balloon brachytherapy catheter: Preclinical treatment planning assessment," Brachytherapy 7(2), 130 (2008).
12. A. Dickler et al., "A dosimetric comparison of MammoSite and clearpath HDR breast brachytherapy devices," Brachytherapy 8, 14-18 (2009).
13. D. Scanderbeg et al., "Clinical implementation of a new HDR brachytherapy device for partial breast irradiation," Radiother. Oncol. 90(1), 36-42 (2009).
14. S. J. Ye et al., "Dose errors due to inhomogeneities in balloon catheter brachytherapy for breast cancer," Int. J. Radiat. Oncol., Biol., Phys. 60(2), 672-677 (2004).
15. B. Kassas et al., "Contrast effects on dosimetry of a partial breast irradiation system," Med. Phys. 31(7), 1976-1979 (2004).
16. S. Oh et al., "Measurements of dose discrepancies due to inhomogeneities and radiographic contrast in balloon catheter brachytherapy," Med. Phys. 36(9), 3945-3954 (2009).
17. D. W. O. Rogers et al., "NRC user codes for EGSnrc," CNRC Report No. PIRS-702 (Ottawa, Ontario, Canada, 2003.
18. J. Borg and D. W. O. Rogers, "Spectra and air kerma strength for encapsulated Ir-192 sources," Med. Phys. 26(11), 2441-2444 (1999).
19. 60Co gamma rays," Radiat. Prot. Dosim. 106(1), 33-43 (2003).
20. E. Pantelis et al., "The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: A Monte Carlo verification study," Int. J. Radiat. Oncol., Biol., Phys. 61(5), 1596-1602 (2005).